Oncology Times

Lymphoma & Leukemia Resource Center Blog

    Specified user is not valid
      • Advances in Follicular Lymphoma Management

        Published Jul 03 2018, 03:13 PM by Caitlin Coles

        Follicular lymphoma (FL), the second most common subtype of non-Hodgkin lymphoma (NHL) and the most common indolent NHL, accounts for 35 percent of NHLs in the U.S. FL arises from germinal center B cells, which are usually CD10 positive, CD5 negative, and CD20 and CD19 positive.

      • Evolving Role of Chemotherapy in the Management of CLL

        Published May 15 2018, 03:44 PM by Caitlin Coles

        Chemotherapy and more specifically chemoimmunotherapy has been standard treatment for patients with CLL. Commonly used regimens are FCR (fludarabine, cyclophosphamide, rituximab), BR (bendamustine, rituximab), and chlorambucil plus obinutuzumab.